Johnson and Johnson Australia may be working on a different gene therapy than Calimmune but it is interesting that Johnson and Johnson is interested in a gene therapy for curing HIV.
Calimmune's CAL-1 using Benitec's ddRNAi is currently in human trials ahead of Johnson and Johnson.
Johnson and Johnson May be interested in a partnership with Calimmune later this year or next year assuming the results of the Calimmune trial are as good as we expect.
We do have hints that the Calimmune trial is going GREAT!!!
News 
Market Data 
Discover 
